CIK 0001701108 · Non-accelerated filer<br>Smaller reporting company
Spero Therapeutics, Inc.
Sign in to watch- Ticker
- SPRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-242-1600
- Business address
- 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
- Former names
- Spero Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $42,485
- in 1 filing
Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 95 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | Shukla Sath CEO and President | Grant or award 10b5-1 | +679,501 | 1,252,001 | ||
| 2024-01-02 | Tregoning Kathleen Director | Grant or award · Stock Option (Right to Buy) | +35,604 | $1.12 | $40K | 35,604 |
| 2023-11-13 | Rajavelu Esther See Remarks | Grant or award | +300,000 | 300,000 | ||
| 2023-10-05 | Pottage John C Jr Director | Grant or award | +20,000 | 35,000 | ||
| 2023-10-05 | Smith Cynthia Director | Grant or award | +20,000 | 35,000 | ||
| 2023-10-05 | THOMAS FRANK E Director | Grant or award | +20,000 | 35,000 | ||
| 2023-10-05 | Deshpande Milind Director | Grant or award | +20,000 | 51,454 | ||
| 2023-10-05 | Tregoning Kathleen Director | Grant or award | +20,000 | 35,000 | ||
| 2023-10-05 | VINK PATRICK V.J.J. Director | Grant or award | +20,000 | 35,000 | ||
| 2023-10-05 | Jackson Scott Thomas Director | Grant or award | +20,000 | 35,000 | ||
| 2023-10-05 | Mahadevia Ankit Director | Grant or award | +20,000 | 808,792 | ||
| 2023-09-13 | HAMED KAMAL Chief Medical Officer | Sale | −39,496 | $1.27 | $50K | 576,461 |
| 2023-08-29 | Shukla Sath CEO and President | Sale 10b5-1 | −4,163 | $1.30 | $5K | 572,500 |
| 2023-08-28 | Keutzer Timothy Chief Development Officer | Sale | −1,854 | $1.26 | $2K | 325,290 |
| 2023-08-28 | JOSEPH TAMARA L Chief Legal Officer | Sale | −1,854 | $1.26 | $2K | 322,790 |
| 2023-08-28 | Mahadevia Ankit Director | Sale | −9,040 | $1.26 | $11K | 788,792 |
| 2023-08-28 | Shukla Sath CEO and President | Sale 10b5-1 | −1,854 | $1.26 | $2K | 576,663 |
| 2023-08-01 | Shukla Sath CEO and President | Grant or award | +266,000 | 578,517 | ||
| 2023-06-12 | HAMED KAMAL Chief Medical Officer | Grant or award | +140,000 | 615,957 | ||
| 2023-02-03 | Mahadevia Ankit CEO and President | Sale | −12,286 | $1.81 | $22K | 797,832 |
Page 5 of 8 · 157 trades